3-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-N-(8-((2-(1-methyl-2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)octyl)propanamide

ID: ALA4442491

Chembl Id: CHEMBL4442491

PubChem CID: 155515813

Max Phase: Preclinical

Molecular Formula: C47H56ClFN8O8

Molecular Weight: 915.46

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(CCC(=O)NCCCCCCCCOc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1

Standard InChI:  InChI=1S/C47H56ClFN8O8/c1-54-42(59)16-15-37(46(54)61)57-45(60)32-11-9-12-38(43(32)47(57)62)64-25-8-6-4-3-5-7-18-50-41(58)17-20-56-23-21-55(22-24-56)19-10-26-65-40-28-33-36(29-39(40)63-2)51-30-52-44(33)53-31-13-14-35(49)34(48)27-31/h9,11-14,27-30,37H,3-8,10,15-26H2,1-2H3,(H,50,58)(H,51,52,53)

Standard InChI Key:  XFUDPXQGWCYCCR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4442491

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3255 (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 915.46Molecular Weight (Monoisotopic): 914.3894AlogP: 6.23#Rotatable Bonds: 22
Polar Surface Area: 175.84Molecular Species: NEUTRALHBA: 13HBD: 2
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.92CX Basic pKa: 8.07CX LogP: 5.21CX LogD: 4.46
Aromatic Rings: 4Heavy Atoms: 65QED Weighted: 0.07Np Likeness Score: -1.01

References

1. Cheng M, Yu X, Lu K, Xie L, Wang L, Meng F, Han X, Chen X, Liu J, Xiong Y, Jin J..  (2020)  Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders.,  63  (3): [PMID:31895569] [10.1021/acs.jmedchem.9b01566]

Source